Upstate Active Clinical Trials Seeking Participants

Cancer Clinical Trials

• 5585
  A Phase I/II Study in Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer.
• CIRB#112
  A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer
• 16
  A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer (NSABP B-39 / RTOG 0413)
• 5849
  A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy
• 3811F
  Allogeneic Hematopoietic Stem Cell Transplanation for CLL, CML, AML, ALL, Myelodysplasia and Non-Hodgkin?s Lymphoma after Total Body Irradiation and Cyclophosphamide Conditioning or Cyclophosphamide and ATG Conditioning For Aplastic Anemia.
• 4130
  Allogeneic Peripheral Blood Stem Cell Transplant Utilizing Non-Myeloablative Conditioning Therapy. A Phase II Study.
• 3260
  Autologous Hematopoietic Stem Cell and/or Bone Marrow Transplantation after High Dose Chemotherapy (Carboplatinum, Etoposide) in Patients with Recurrent/Refractory Germ Cell Tumors
• 3311
  Autologous Hematopoietic Stem Cell Transplantation After Melphalan with or without Total Body Irradiation for Multiple Myeloma.
• 4429
  Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First or Second Remission.
• 82
  CALGB 30607: Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer
• 77
  Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Recieving Cisplatan and Etopside.
• CIRB117
  A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
• CIRB113
  Phase III Randomized Study of Sorafenib (IND 69896, NSC 724772) Plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC)
• 55
  CALGB 90203:Randomized Phase III Study of Neo-adjuvant Docetaxel and Androgen Deprivation prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
• 62
  ECOG E1505:A Phase III Randomized Trial of Adjuvant Chemotherapy with or Without Bevacizumab for Patients with Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)
• 4165
  High Dose Cyclophosphamide, BCNU, Etoposide & Autologous Hematopoietic Stem Cell Transplantation for Resistant & Relapsed Hodgkin's Disease.
• 4160
  High Dose Cyclophosphamide, Thiotepa & Etoposide Followed by Autologous Hematopoietic Stem Cell Transplantation (Intermediate & High Grade).
• 5035
  Study Drug Versus Other Chemotherapeutic Agents For Third-Line Single Agent Treatment of Patients With Relapsed Aggressive Non-Hodgkin?s Lymphoma: A Randomized, Controlled, Phase III Comparative Trial.
• 5241
  Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
• CIRB126
  Randomized Phase III Trial Comparing Everolimus Plus Placebo Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment with Tyrosine Kinase Inhibitors
• 5414
  S0424: Molecular Epidemiology Case Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
• CIRB122
  Study Title: Z6051: A Phase III Prospective Randomized Trial Comparing Laparoscopic-assisted Resection Versus Open Resection for Rectal Cancer

Search Again